Table 6.

The significant KEGG pathways of the predicted human proteins.

KEGG Pathway	Protein Count	Predicted Human Proteins
Proteasome (p = 2.3615E-8)	19	PSMB10, SHFM1, PSMB8, PSMA2, PSMB4, PSMC5, PSMD12, PSMA6, PSMB1, PSMC4, PSMA5, PSMC3, PSMC2, PSMD1, PSMC1, PSMB2, POMP, PSMD4, PSMD7
Endocytosis (p = 2.5126E-7)	49	LDLR, CHMP4B, TSG101, CHMP5, CAPZA2, CHMP6, PIP5K1C, CLTC, SMAP1, PIP5KL1, VPS4B, SPG21, KIF5B, KIF5A, RAB4A, HLA-A, HLA-B, HLA-E, HLA-F, ARPC1A, ARPC1B, RAB11FIP5, RAB11FIP3, CHMP1B, ACAP3, ACAP1, RAB5A, SH3GL1, VPS29, SNX5, SNX2, SNX1, ARPC4, HSPA1A, SNX4, ARPC5, ARFGEF2, CHMP2B, SH3GLB1, RAB11A, EHD1, EHD2, RAB31, ARF1, RAB35, ARF3, RAB22A, VPS28, DNM1
Biosynthesis of antibiotics (p = 7.0351E-5)	44	LDOA, HSD17B10, LDHB, LDHA, ADPGK, PGAM1, HK2, HK1, ASL, AGXT, PDHB, FDFT1, GOT1, IDH3G, HK3, ENO2, IDH2, GCSH, IDH1, ENO3, PDHA2, CAT, RPIA, PDHA1, HADH, ENO1, SHMT1, PFKL, AK1, SUCLG1, FDPS, IDH3B, ACLY, PFKM, IDH3A, NME5, ALDH7A1, PYCR2, NME2, PKLR, MVK, PRPS2, CBS, PRPS1
Carbon metabolism (p = 1.02674E-6)	29	ALDOA, ADPGK, GLUD1, PGAM1, HK2, HK1, AGXT, PDHB, GOT1, IDH3G, HK3, IDH2, ENO2, IDH1, ENO3, PDHA2, CAT, RPIA, PDHA1, ENO1, SHMT1, PFKL, SUCLG1, IDH3B, PFKM, IDH3A, PKLR, PRPS2, PRPS1
Biosynthesis of amino acids (p = 5.6641E-6)	21	ALDOA, SHMT1, PFKL, PGAM1, IDH3B, PFKM, ASL, IDH3A, PYCR2, GOT1, IDH3G, PKLR, ENO2, IDH2, ENO3, IDH1, RPIA, PRPS2, CBS, ENO1, PRPS1
Glycolysis/Gluconeogenesis (p = 6.9568E-6)	20	ALDOA, LDHB, LDHA, PFKL, ADPGK, HK2, PGAM1, HK1, PFKM, PDHB, ALDH3A1, G6PC, ALDH7A1, HK3, PKLR, ENO2, ENO3, PDHA2, PDHA1, ENO1
Central carbon metabolism in cancer (p = 6.3733E-4)	16	PFKL, MET, HK2, PGAM1, RAF1, HK1, SIRT6, PFKM, PDHB, SLC16A3, SLC1A5, HK3, PDGFRB, PDHA2, MTOR, PDHA1